QBiotics prepares for a new capital raise
QBiotics Group Limited has lodged a board-approved prospectus with the Australian corporate regulator the Australian Securities and Investments Commission (ASIC) on 26 October 2018. ASIC will review the prospectus over the next 7-14 days. For the protection of all shareholders the company has halted the Off Market Trading in shares during this prospectus review period, to ensure all investors can be fully informed. A draft of the prospectus (without an application form) can be obtained now from qbiotics.com/prospectus. Once approved by ASIC the final prospectus will be made available to shareholders on or before 16 November 2018.